Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer

Clinical Epigenetics

Volumn 6, Issue 1, 2014, Pages

  Guo, Shicheng ^a   Tan, Lixing ^a   Pu, Weilin ^a   Wu, Junjie ^a,b   Xu, Kuan ^c   Wu, Jinhui ^d   Li, Qiang ^b   Ma, Yanyun ^a   Xu, Jibin ^b   Jin, Li ^a   Wang, Jiucun ^a  

^a FUDAN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d QINGDAO UNIVERSITY   (China)

Author keywords

APC; Biomarker; Diagnosis; DNA methylation; Meta analysis; NSCLC; TCGA

Indexed keywords

BIOLOGICAL MARKER;

APC QGENE; ARTICLE; CANCER DIAGNOSIS; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; GENE FUNCTION; GENETIC ANALYSIS; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

EID: 84901331440     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/1868-7083-6-5     Document Type: Article

References (41)

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
2. Nesbitt JC, Putnam JB Jr, Walsh GL, Roth JA, Mountain CF: Survival in early-stage non-small cell lung cancer. Ann Thorac Surg 1995, 60:466-472.
3. Gokul G, Khosla S: DNA methylation and cancer. Subcell Biochem 2012, 61:597-625.
4. Dietrich D, Hasinger O, Liebenberg V, Field JK, Kristiansen G, Soltermann A: DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients. Diagn Mol Pathol 2012, 21:93-104.
5. Dietrich D, Kneip C, Raji O, Liloglou T, Seegebarth A, Schlegel T, Flemming N, Rausch S, Distler J, Fleischhacker M, Schmidt B, Giles T, Walshaw M, Warburton C, Liebenberg V, Field JK: Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates. Int J Oncol 2012, 40:825-832.
6. Fodde R, Kuipers J, Rosenberg C, Smits R, Kielman M, Gaspar C, van Es JH, Breukel C, Wiegant J, Giles RH, Clevers H: Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 2001, 3:433-438. (Pubitemid 32288454)
7. Deng G, Song GA, Pong E, Sleisenger M, Kim YS: Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor. Cancer Res 2004, 64:2692-2698. (Pubitemid 38500603)
8. Gu J, Wen Y, Zhu S, Hua F, Zhao H, Xu H, You J, Sun L, Wang W, Chen J, Zhou Q: Association between P (16INK4a) promoter methylation and non-small cell lung cancer: a meta-analysis. PLoS One 2013, 8:e60107.
9. Chen Y, Li J, Yu X, Li S, Zhang X, Mo Z, Hu Y: APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis. Eur J Hum Genet 2013, 21:929-935.
10. Usadel H, Brabender J, Danenberg KD, Jeronimo C, Harden S, Engles J, Danenberg PV, Yang S, Sidransky D: Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002, 62:371-375. (Pubitemid 34106406)
11. Tsou JA, Hagen JA, Carpenter CL, Laird-Offringa IA: DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene 2002, 21:5450-5461. (Pubitemid 34983481)
12. Begum S, Brait M, Dasgupta S, Ostrow KL, Zahurak M, Carvalho AL, Califano JA, Goodman SN, Westra WH, Hoque MO, Sidransky D: An epigenetic marker panel for detection of lung cancer using cell-free serum DNA. Clin Cancer Res 2011, 17:4494-4503.
13. Brabender J, Usadel H, Danenberg KD, Metzger R, Schneider PM, Lord RV, Wickramasinghe K, Lum CE, Park J, Salonga D, Singer J, Sidransky D, Holscher AH, Meltzer SJ, Danenberg PV: Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene 2001, 20:3528-3532. (Pubitemid 32619405)
14. Feng Q, Hawes SE, Stern JE, Wiens L, Lu H, Dong ZM, Jordan CD, Kiviat NB, Vesselle H: DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 2008, 17:645-654. (Pubitemid 351469215)
15. Jin M, Kawakami K, Fukui Y, Tsukioka S, Oda M, Watanabe G, Takechi T, Oka T, Minamoto T: Different histological types of non-small cell lung cancer have distinct folate and DNA methylation levels. Cancer Sci 2009, 100:2325-2330.
16. Kim DS, Cha SI, Lee JH, Lee YM, Choi JE, Kim MJ, Lim JS, Lee EB, Kim CH, Park TI, Jung TH, Park JY: Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population. Lung Cancer 2007, 58:1-6. (Pubitemid 47379959)
17. Lin Q, Geng J, Ma K, Yu J, Sun J, Shen Z, Bao G, Chen Y, Zhang H, He Y, Luo X, Feng X, Zhu J: RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage i non-small cell lung cancer in China. J Cancer Res Clin Oncol 2009, 135:1675-1684.
18. Pan SY, Xie EF, Shu YQ, Gao L, Zhang LX, Chen D, Chen JB, Zhao WJ, Mu Y, Zhang JN: Methylation quantification of adenomatous polyposis coli (APC) gene promoter in plasma of lung cancer patients. Ai Zheng 2009, 28:384-389.
19. Rykova EY, Skvortsova TE, Laktionov PP, Tamkovich SN, Bryzgunova OE, Starikov AV, Kuznetsova NP, Kolomiets SA, Sevostianova NV, Vlassov VV: Investigation of tumor-derived extracellular DNA in blood of cancer patients by methylation-specific PCR. Nucleosides Nucleotides Nucleic Acids 2004, 23:855-859. (Pubitemid 39456485)
20. Shivapurkar N, Stastny V, Suzuki M, Wistuba II, Li L, Zheng Y, Feng Z, Hol B, Prinsen C, Thunnissen FB, Gazdar AF: Application of a methylation gene panel by quantitative PCR for lung cancers. Cancer Lett 2007, 247:56-71. (Pubitemid 44959413)
21. Suzuki M, Shigematsu H, Iizasa T, Hiroshima K, Nakatani Y, Minna JD, Gazdar AF, Fujisawa T: Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer. Cancer 2006, 106:2200-2207. (Pubitemid 43673242)
22. Topaloglu O, Hoque MO, Tokumaru Y, Lee J, Ratovitski E, Sidransky D, Moon CS: Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res 2004, 10:2284-2288. (Pubitemid 38445685)
23. Vallbohmer D, Brabender J, Yang D, Schneider PM, Metzger R, Danenberg KD, Holscher AH, Danenberg PV: DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value. Clin Lung Cancer 2006, 8:39-44. (Pubitemid 44336242)
24. Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, Farinas AJ, Milchgrub S, Euhus DM, Gilcrease M, Herman J, Minna JD, Gazdar AF: Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin Cancer Res 2001, 7:1998-2004. (Pubitemid 32994838)
25. Wang Y, Zhang D, Zheng W, Luo J, Bai Y, Lu Z: Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray. Cancer 2008, 112:1325-1336. (Pubitemid 351429748)
26. Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y, Motoyama T: Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci 2003, 94:589-592. (Pubitemid 36975012)
27. Zhang Y, Wang R, Song H, Huang G, Yi J, Zheng Y, Wang J, Chen L: Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer. Cancer Lett 2011, 303:21-28.
28. Ignatov A, Bischoff J, Ignatov T, Schwarzenau C, Krebs T, Kuester D, Costa SD, Roessner A, Semczuk A, Schneider-Stock R: APC promoter hypermethylation is an early event in endometrial tumorigenesis. Cancer Sci 2010, 101:321-327.
29. Wu T, Giovannucci E, Welge J, Mallick P, Tang WY, Ho SM: Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis. Br J Cancer 2011, 105:65-73.
30. Purnak T, Ozaslan E, Efe C: Molecular basis of colorectal cancer. N Engl J Med 2010, 362:1246-1247.
31. Eissa S, Swellam M, El-Khouly IM, Kassim SK, Shehata H, Mansour A, Esmat M, Nossier AI, Hamdy MA, Awad NM, El-Ahmady O: Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer. Cancer Epidemiol Biomarkers Prev 2011, 20:1657-1664.
32. Trock BJ, Brotzman MJ, Mangold LA, Bigley JW, Epstein JI, McLeod D, Klein EA, Jones JS, Wang S, McAskill T, Mehrotra J, Raghavan B, Partin AW: Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies. BJU Int 2012, 110:56-62.
33. Sozzi G, Conte D, Mariani L, Lo Vullo S, Roz L, Lombardo C, Pierotti MA, Tavecchio L: Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 2001, 61:4675-4678. (Pubitemid 32691874)
34. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG: Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999, 59:67-70. (Pubitemid 29062958)
35. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R: DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001, 61:1659-1665. (Pubitemid 34292602)
36. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003, 327: 557-560. (Pubitemid 37088507)
37. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. (Pubitemid 17189972)
38. Huizenga HM, Visser I, Dolan CV: Testing overall and moderator effects in random effects meta-regression. Br J Math Stat Psychol 2011, 64:1-19.
39. Midgette AS, Stukel TA, Littenberg B: A meta-analytic method for summarizing diagnostic test performances: receiver-operating-characteristic- summary point estimates. Med Decis Making 1993, 13:253-257. (Pubitemid 23199345)
40. Jones CM, Athanasiou T: Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg 2005, 79:16-20. (Pubitemid 40037431)
41. Sproul D, Nestor C, Culley J, Dickson JH, Dixon JM, Harrison DJ, Meehan RR, Sims AH, Ramsahoye BH: Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. Proc Natl Acad Sci USA 2011, 108:4364-4369.